Immunarray
Immunarray39
About
What does Immunarray do?
ImmunArray is a biotechnology company focused on the development and commercialization of advanced diagnostic tools for autoimmune and neurological disorders. Their proprietary iCHIP microarray platform enables the detection of multiple biomarkers from a single blood sample, aiming to improve diagnosis and management of complex immune-mediated diseases.
What is Immunarray's revenue?
StartupHub estimates Immunarray's annual revenue at $5.2M (range $2.3M to $7.5M, 30% confidence), based on comparable companies in the sector.
What is Immunarray's valuation?
StartupHub estimates Immunarray's effective valuation at $37.8M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Immunarray raised?
Immunarray has raised a total of $10M in funding. The most recent round on record is Series A.
Where is Immunarray headquartered?
Immunarray is headquartered in Richmond, United States.
When was Immunarray founded?
Immunarray was founded in 2006.
What industry does Immunarray operate in?
Immunarray operates in Healthcare, Blood, Diagnostics, Immunology, Biomarkers, Biotech.
What is Immunarray's current status?
Immunarray's current operating status is: Inactive.
An entrant is a company tagged Healthcare whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.